AXSM in the 13F filings
Axsome Therapeutics Inc · CUSIP 05464T104
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 30
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 10 listed it in both
- Shares listed
- 8,144,284
- combined, among listed positions
- Reported value
- $1.4bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 18 buyers (opened or added shares) and 14 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +499,559.
Managers listing AXSM in Q1 2026
30 of 30 holders
Largest increases and reductions, by shares
Increases
- Point72 Asset Management LPexisting position · 424,750 shares now+406,751
- Fidelity (FMR LLC)existing position · 1,566,995 shares now+385,373
- Two Sigma Investments LPexisting position · 322,778 shares now+177,181
- Citadel Advisors LLCexisting position · 281,503 shares now+143,290
- D. E. Shaw & Co.existing position · 603,465 shares now+54,352
Reductions
- T. Rowe Price Associates Incexisting position · 1,317,059 shares now-192,811
- Marshall Wace LLPexisting position · 141,236 shares now-179,332
- Jane Street Group LLCexisting position · 4,078 shares now-133,205
- Man Group PLCexisting position · 142,271 shares now-86,370
- Wellington Management Group LLPexisting position · 1,145,306 shares now-76,350
New positions and exits
New (5)
Exited (3)
- Quantbot Technologies LPwas $3.5m
- Verition Fund Management LLCwas $623k
- Brevan Howard Capital Management LPwas $226k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2017 | 1 | $338k | n.a. | n.a. |
| Q3 2018 | 1 | $62k | n.a. | n.a. |
| Q1 2019 | 2 | $2.7m | n.a. | n.a. |
| Q2 2019 | 2 | $16m | n.a. | n.a. |
| Q3 2019 | 2 | $11m | n.a. | n.a. |
| Q4 2019 | 7 | $162m | n.a. | n.a. |
| Q1 2020 | 5 | $48m | n.a. | n.a. |
| Q2 2020 | 3 | $26m | n.a. | n.a. |
| Q3 2020 | 1 | $2.1m | n.a. | n.a. |
| Q1 2021 | 1 | $2.5m | n.a. | n.a. |
| Q3 2021 | 2 | $12m | n.a. | n.a. |
| Q1 2022 | 2 | $12m | n.a. | n.a. |
| Q2 2022 | 1 | $2.6m | n.a. | n.a. |
| Q3 2022 | 2 | $37m | n.a. | n.a. |
| Q4 2022 | 4 | $75m | n.a. | n.a. |
| Q1 2023 | 4 | $146m | n.a. | n.a. |
| Q2 2023 | 6 | $92m | n.a. | n.a. |
| Q3 2023 | 4 | $78m | n.a. | n.a. |
| Q4 2023 | 4 | $120m | 3 | 2 |
| Q1 2024 | 3 | $59m | 0 | 2 |
| Q2 2024 | 4 | $65m | 2 | 1 |
| Q3 2024 | 6 | $86m | 4 | 1 |
| Q4 2024 | 3 | $38m | 2 | 0 |
| Q1 2025 | 9 | $222m | 7 | 1 |
| Q2 2025 | 7 | $139m | 6 | 2 |
| Q3 2025 | 5 | $284m | 3 | 3 |
| Q4 2025 | 12 | $806m | 15 | 12 |
| Q1 2026 | 12 | $708m | 18 | 14 |
| Q2 2026 | 17 | $1.4bn | 24 | 11 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
AXSM and LLY →AXSM and JNJ →AXSM and VRTX →Choose a stock to compare with AXSM →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own AXSM, latest filings →Back to the 13F Explorer →